{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T06:02:05Z","timestamp":1772949725304,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002954","name":"University of Milano\u2013Bicocca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101544","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:59:44Z","timestamp":1753891184000},"page":"101544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I"],"prefix":"10.1016","volume":"33","author":[{"given":"Giada","family":"De Ponti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovica","family":"Santi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Dina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Pievani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Donsante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Riminucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaukat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Annoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Quattrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ester","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8105-6476","authenticated-orcid":false,"given":"Marta","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101544_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13052-018-0550-5","article-title":"Mucopolysaccharidoses: early diagnostic signs in infants and children","volume":"44","author":"Galimberti","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.omtm.2025.101544_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911168","article-title":"MPSI Manifestations and Treatment Outcome: Skeletal Focus","volume":"23","author":"De Ponti","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101544_bib3","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2008.095315","article-title":"Musculoskeletal manifestations of lysosomal storage disorders","volume":"68","author":"Aldenhoven","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.omtm.2025.101544_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-017-0583-7","article-title":"Early disease progression of Hurler syndrome","volume":"12","author":"Kiely","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2025.101544_bib5","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1038\/s41598-017-09958-9","article-title":"Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I","volume":"7","author":"Azario","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101544_bib6","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2014-06-581207","article-title":"Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I","volume":"125","author":"Pievani","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101544_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The Clinical Outcome of Hurler Syndrome after Stem Cell Transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2025.101544_bib8","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cells9081838","article-title":"Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology","volume":"9","author":"Hampe","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2025.101544_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00109-020-01935-6","article-title":"Lysosomal storage diseases: current therapies and future alternatives","volume":"98","author":"Leal","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib10","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.bbadis.2011.07.013","article-title":"Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options","volume":"1812","author":"Oussoren","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2025.101544_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ymgme.2020.05.001","article-title":"Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model","volume":"130","author":"Santi","year":"2020","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtm.2025.101544_bib12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI200419205","article-title":"Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells","volume":"113","author":"Biffi","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101544_bib13","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101544_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101313","article-title":"A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB","volume":"32","author":"Crippa","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101544_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001522","article-title":"Identification of Hematopoietic Stem Cell\u2013Specific miRNAs Enables Gene Therapy of Globoid Cell Leukodystrophy","volume":"2","author":"Gentner","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/hum.2014.158","article-title":"Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II","volume":"26","author":"Wakabayashi","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101544_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi8214","article-title":"Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome","volume":"16","author":"Consiglieri","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib18","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/hum.2016.068","article-title":"Preclinical Testing of the Safety and Tolerability of Lentiviral Vector\u2013Mediated Above-Normal Alpha-L-Iduronidase Expression in Murine and Human Hematopoietic Cells Using Toxicology and Biodistribution Good Laboratory Practice Studies","volume":"27","author":"Visigalli","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101544_bib20","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101544_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbr.2012.04.051","article-title":"Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice","volume":"233","author":"Baldo","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.omtm.2025.101544_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","article-title":"Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice","volume":"11","author":"Liu","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101544_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/gim.2014.25","article-title":"The natural history of MPS I: global perspectives from the MPS I Registry","volume":"16","author":"Beck","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement","volume":"11","author":"Hampe","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.omtm.2025.101544_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-017-0662-9","article-title":"Open issues in Mucopolysaccharidosis type I-Hurler","volume":"12","author":"Parini","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2025.101544_bib26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2004.03.011","article-title":"Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human \u03b1-l-iduronidase gene","volume":"9","author":"Hartung","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101544_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","article-title":"Neonatal Gene Therapy of MPS I Mice by Intravenous Injection of a Lentiviral Vector","volume":"11","author":"Kobayashi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101544_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2018.08.031","article-title":"In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR\/Cas9 system","volume":"288","author":"Schuh","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.omtm.2025.101544_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43556-023-00120-8","article-title":"In vivo adenine base editing corrects newborn murine model of Hurler syndrome","volume":"4","author":"Su","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.omtm.2025.101544_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymgme.2006.08.001","article-title":"Effect of neonatal administration of a retroviral vector expressing \u03b1-l-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice","volume":"90","author":"Chung","year":"2007","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtm.2025.101544_bib31","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41591-018-0195-3","article-title":"Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans","volume":"24","author":"Scala","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101544_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpeds.2016.08.033","article-title":"Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I","volume":"178","author":"Laraway","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.omtm.2025.101544_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: Management and Treatment Guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2025.101544_bib35","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101544_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40478-017-0464-2","article-title":"Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease","volume":"5","author":"Hordeaux","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2025.101544_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/JND-190426","article-title":"Advancements in AAV-mediated Gene Therapy for Pompe Disease","volume":"7","author":"Salabarria","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtm.2025.101544_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41573-019-0020-9","article-title":"Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges","volume":"18","author":"Cavazzana","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2025.101544_bib39","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI62189","article-title":"Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations","volume":"122","author":"Cesana","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101544_bib40","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1172\/JCI61852","article-title":"Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts","volume":"122","author":"Moiani","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101544_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233151","article-title":"Lentivirus-based Gene Therapy of Hematopoietic Stem Cells in Wiskott-Aldrich Syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101544_bib42","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","article-title":"Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection","volume":"117","author":"Biffi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101544_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/science.1233158","article-title":"Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101544_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","article-title":"Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis","volume":"125","author":"Khan","year":"2018","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtm.2025.101544_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-009-9036-3","article-title":"Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2025.101544_bib46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/jcm9020396","article-title":"Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms","volume":"9","author":"Viana","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib47","article-title":"Biomarkers in patients with mucopolysaccharidosis type II and IV","volume":"19","author":"Fujitsuka","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtm.2025.101544_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.624988","article-title":"Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement","volume":"8","author":"Sevin","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtm.2025.101544_bib49","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/nn2015","article-title":"Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions","volume":"10","author":"Mildner","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2025.101544_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymgme.2013.03.005","article-title":"Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice","volume":"109","author":"Baldo","year":"2013","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omtm.2025.101544_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10545-015-9900-2","article-title":"Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?","volume":"39","author":"Tomatsu","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2025.101544_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173449","article-title":"Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells","volume":"9","author":"Donsante","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2025.101544_bib53","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1074\/jbc.M310349200","article-title":"Regulation of Collagenase Activities of Human Cathepsins by Glycosaminoglycans","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101544_bib54","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2353\/ajpath.2009.090211","article-title":"Glycosaminoglycan-Mediated Loss of Cathepsin K Collagenolytic Activity in MPS I Contributes to Osteoclast and Growth Plate Abnormalities","volume":"175","author":"Wilson","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2025.101544_bib55","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","article-title":"Hematopoietic Cell Transplantation for Mucopolysaccharidosis Patients Is Safe and Effective: Results after Implementation of International Guidelines","volume":"21","author":"Aldenhoven","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2025.101544_bib56","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning","volume":"121","author":"Boelens","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101544_bib57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpeds.2016.11.036","article-title":"Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management","volume":"182","author":"Clarke","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.omtm.2025.101544_bib58","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/gim.2016.223","article-title":"Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1","volume":"19","author":"Grosse","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib59","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm0798-775","article-title":"T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates","volume":"4","author":"Kohn","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101544_bib60","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.omtm.2022.07.018","article-title":"Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper","volume":"26","author":"Yang","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101544_bib61","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ymthe.2019.04.014","article-title":"Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease","volume":"27","author":"Squeri","year":"2019","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:05:58Z","timestamp":1772903158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001391"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101544","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101544"}}